• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物辨别与主观效应评分之间的关系:对评估和理解人类中右旋苯丙胺滥用潜力的启示。

Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.

作者信息

Reynolds Anna R, Bolin B Levi, Stoops William W, Rush Craig R

机构信息

Department of Psychology, University of Kentucky College of Arts and Sciences Departments of bBehavioral Science cPsychiatry, University of Kentucky College of Medicine, Lexington, KY 40536-0086, USA.

出版信息

Behav Pharmacol. 2013 Sep;24(5-6):523-32. doi: 10.1097/FBP.0b013e328364505f.

DOI:10.1097/FBP.0b013e328364505f
PMID:23851485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058093/
Abstract

The discriminative and subjective effects of drugs in humans are related, but the full extent of this relationship remains to be determined. To further explore this relationship, a retrospective analysis was conducted on data from six studies completed in our laboratory that used identical procedures. The relationship between the discriminative and subjective effects of a range of doses of D-amphetamine (i.e. 2.5-15 mg) was examined using correlational analyses. Significant correlations with discrimination performance were observed on 15 of 20 items from the Drug-Effect Questionnaire across a range of qualities [e.g. Pay For (a positive effect indicative of abuse potential) and Active (a stimulant-like effect)], but the magnitude of these relationships was modest (r<0.52). The current findings demonstrate that diverse subjective effects contribute to the discriminative effects of D-amphetamine and indicate that the former are a more practical means to assess the abuse potential of drugs. Although these procedures are fundamentally related in that they rely on the presence of an interoceptive drug state, they differ in the dimension(s) of the interoceptive effects that participants must quantify. The simultaneous use of drug discrimination and subjective effects may, therefore, reveal complimentary aspects of drug effects that underlie their potential for abuse.

摘要

药物在人体中的辨别性和主观效应是相关的,但这种关系的全貌仍有待确定。为了进一步探究这种关系,我们对在本实验室完成的六项采用相同程序的研究数据进行了回顾性分析。使用相关分析考察了一系列剂量的右旋苯丙胺(即2.5 - 15毫克)的辨别性和主观效应之间的关系。在《药物效应问卷》的20个项目中的15个项目上,观察到与辨别性能存在显著相关性,涉及一系列特质[例如“为其付出代价”(一种表明滥用潜力的积极效应)和“活跃”(一种类似兴奋剂的效应)],但这些关系的强度适中(r < 0.52)。当前研究结果表明,多种主观效应促成了右旋苯丙胺的辨别性效应,并表明前者是评估药物滥用潜力的更实用手段。尽管这些程序在根本上是相关的,因为它们都依赖于内感受性药物状态的存在,但参与者必须量化的内感受性效应的维度有所不同。因此,同时使用药物辨别和主观效应可能会揭示药物效应中与滥用潜力相关的互补方面。

相似文献

1
Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.药物辨别与主观效应评分之间的关系:对评估和理解人类中右旋苯丙胺滥用潜力的启示。
Behav Pharmacol. 2013 Sep;24(5-6):523-32. doi: 10.1097/FBP.0b013e328364505f.
2
Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?口服右旋苯丙胺自我给药与主观效应评分之间的关系:主观效应评分是否与药物摄取行为的渐进比率测量相对应?
Behav Pharmacol. 2013 Sep;24(5-6):533-42. doi: 10.1097/FBP.0b013e3283645047.
3
Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.评估雌二醇给药对健康绝经前女性中右旋苯丙胺的辨别刺激和受试者自评效应的影响。
Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):258-66. doi: 10.1016/j.pbb.2007.04.022. Epub 2007 May 5.
4
Similar discriminative-stimulus effects of D-amphetamine in women and men.右旋苯丙胺对女性和男性具有相似的辨别性刺激效应。
Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):289-96. doi: 10.1016/j.pbb.2007.05.003. Epub 2007 May 13.
5
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.甲基苯丙胺、右旋苯丙胺、哌醋甲酯和三唑仑对甲基苯丙胺训练的人类的辨别性刺激和主观评定效应
J Pharmacol Exp Ther. 2009 Mar;328(3):1007-18. doi: 10.1124/jpet.108.147124. Epub 2008 Dec 22.
6
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.奥沙西泮不会调节右旋苯丙胺对人类的行为影响。
Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. doi: 10.1016/j.pbb.2005.08.012. Epub 2005 Sep 22.
7
Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.对右旋苯丙胺主观积极反应峰值时间的个体差异:与药代动力学和生理学的关系。
J Psychopharmacol. 2016 Apr;30(4):330-43. doi: 10.1177/0269881116631650. Epub 2016 Feb 15.
8
Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.压力引起的情绪变化和皮质醇释放可预测安非他命对情绪的影响。
Drug Alcohol Depend. 2010 Jun 1;109(1-3):175-80. doi: 10.1016/j.drugalcdep.2009.12.029. Epub 2010 Feb 21.
9
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.哌甲酯和右旋苯丙胺对滥用兴奋剂的人类的强化作用、主观评定、行为表现及生理效应
J Psychopharmacol. 2004 Dec;18(4):534-43. doi: 10.1177/0269881104047281.
10
Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.人类中安非他命的行为效应:亚临床水平的注意力不集中和多动的影响。
Am J Drug Alcohol Abuse. 2010 Jul;36(4):220-7. doi: 10.3109/00952990.2010.494213.

引用本文的文献

1
A Brief Introduction to Human Behavioral Pharmacology: Methods, Design Considerations and Ethics.《人类行为药理学简介:方法、设计考量与伦理学》
Perspect Behav Sci. 2022 Mar 1;45(2):361-381. doi: 10.1007/s40614-022-00330-5. eCollection 2022 Jun.
2
Human drug discrimination: A primer and methodological review.人类药物辨别:入门指南与方法学综述。
Exp Clin Psychopharmacol. 2016 Aug;24(4):214-28. doi: 10.1037/pha0000077.
3
Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis.曲马多的μ阿片介导的辨别刺激效应:个体受试者分析
J Exp Anal Behav. 2015 Mar;103(2):361-74. doi: 10.1002/jeab.137. Epub 2015 Feb 9.

本文引用的文献

1
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.阿托莫西汀滥用潜力评估综述:一种用于治疗注意缺陷多动障碍的非兴奋剂药物。
Psychopharmacology (Berl). 2013 Mar;226(2):189-200. doi: 10.1007/s00213-013-2986-z. Epub 2013 Feb 9.
2
Abuse liability assessment of atomoxetine in a drug-abusing population.药物滥用人群中托莫西汀的滥用可能性评估
Drug Alcohol Depend. 2008 May 1;95(1-2):140-6. doi: 10.1016/j.drugalcdep.2008.01.008. Epub 2008 Mar 6.
3
Similar discriminative-stimulus effects of D-amphetamine in women and men.右旋苯丙胺对女性和男性具有相似的辨别性刺激效应。
Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):289-96. doi: 10.1016/j.pbb.2007.05.003. Epub 2007 May 13.
4
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.低剂量阿立哌唑可减弱右旋苯丙胺的主观效应。
Drug Alcohol Depend. 2006 Sep 15;84(2):206-9. doi: 10.1016/j.drugalcdep.2006.02.004. Epub 2006 Mar 15.
5
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.奥沙西泮不会调节右旋苯丙胺对人类的行为影响。
Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. doi: 10.1016/j.pbb.2005.08.012. Epub 2005 Sep 22.
6
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.阿立哌唑可减弱D-苯丙胺对人类的辨别刺激和主观评定效应。
Neuropsychopharmacology. 2005 Nov;30(11):2103-14. doi: 10.1038/sj.npp.1300803.
7
Alprazolam attenuates the behavioral effects of d-amphetamine in humans.阿普唑仑可减弱右旋苯丙胺对人体的行为影响。
J Clin Psychopharmacol. 2004 Aug;24(4):410-20. doi: 10.1097/01.jcp.0000130553.55630.ad.
8
Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.三唑仑-苯丙胺相互作用:对记忆和唤醒作用的解离
J Psychopharmacol. 2003 Mar;17(1):17-29. doi: 10.1177/0269881103017001689.
9
Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.利培酮可减弱右旋苯丙胺对人类的辨别刺激效应。
J Pharmacol Exp Ther. 2003 Jul;306(1):195-204. doi: 10.1124/jpet.102.048439. Epub 2003 Apr 3.
10
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers.急性服用氟哌啶醇或利培酮对健康志愿者甲基苯丙胺主观反应的影响。
Drug Alcohol Depend. 2002 Sep 1;68(1):23-33. doi: 10.1016/s0376-8716(02)00104-7.